Catalog
Disorders due to use of methylene-dioxymethamphetamine [MDMA] or related drugs, including methylene-dioxyamphetamine [MDA]
Link to WHO Definition
Disorders due to use of methylene-dioxymethamphetamine [MDMA] or related drugs, including methylene-dioxyamphetamine [MDA] – http://id.who.int/icd/entity/1218193465
Disorders due to use of MDMA (methylene-dioxymethamphetamine) or related drugs, including MDA (methylene-dioxyamphetamine) are characterised by the pattern and consequences of MDMA or related drug use. MDMA is a common drug of abuse in many countries especially among young people. It is predominantly available in tablet form known as ‘ecstasy’. Pharmacologically, MDMA has stimulant and empathogenic properties and these encourage its use among young people for social and other interactions. Considering its wide prevalence in many countries and among many sub-groups of young people, MDMA and Related Drug Dependence and MDMA and Related Drug Withdrawal are comparatively uncommon. Substance-Induced Mental Disorders may arise from its use. Several analogues of MDMA exist, including MDA.
Parents
Children
- 6C4C.7 Certain specified MDMA or related drug-induced mental or behavioural disorders, including MDA
- 6C4C.0 Episode of harmful use of MDMA or related drugs, including MDA
- 6C4C.3 MDMA or related drug intoxication, including MDA
- 6C4C.6 MDMA or related drug-induced psychotic disorder, including MDA
- 6C4C.1 Harmful pattern of use of MDMA or related drugs, including MDA
- 6C4C.4 MDMA or related drug withdrawal, including MDA
- 6C4C.5 MDMA or related drug-induced delirium, including MDA
- 6C4C.2 MDMA or related drug dependence, including MDA